| 2026-07-30 | Press release | Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026 |
| 2026-07-30 | Press release | Bristol Myers Squibb Reports Second Quarter Financial Results for 2026 |
| 2026-07-30 | Press release | Jul 30, 2026, 6:59 AM ET Bristol Myers Squibb Reports Second Quarter Financial Results for 2026 Read Press Release |
| 2026-07-30 | Earnings deck | Q2 2026 Results Presentation (with Appendix) (PDF) |
| 2026-07-30 | Earnings deck | Q2 2026 Results Presentation (PDF) |
| 2026-07-30 | Press release | Press release (PDF) |
| 2026-07-13 | Press release | Jul 13, 2026, 6:59 AM ET U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezig |
| 2026-06-09 | Press release | Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference |
| 2026-06-08 | Press release | Jun 8, 2026, 6:59 AM ET Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campai |
| 2026-06-02 | Press release | Jun 2, 2026, 8:00 AM ET Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaning |
| 2026-05-31 | Press release | Learn More |
| 2026-05-30 | Press release | Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Pati |
| 2026-05-27 | Press release | Learn More |
| 2026-05-26 | Press release | Learn More |
| 2026-05-14 | Press release | Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026 |
| 2026-05-12 | Press release | Bristol Myers Squibb and Hengrui Pharma Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, H |
| 2026-04-30 | Press release | Press Release (PDF) |
| 2026-04-30 | Press release | Bristol Myers Squibb Reports First Quarter Financial Results for 2026 |
| 2026-04-10 | ESG report | BMS Modern Slavery Statement (PDF) |
| 2026-03-28 | Press release | Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology |
| 2026-03-02 | Press release | Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference |
| 2026-02-20 | Press release | Abraxane CVR notification |
| 2026-02-05 | Press release | Press Release (PDF) |
| 2026-02-05 | Press release | Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025 |
| 2026-02-05 | Press release | Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026 |
| 2026-01-12 | Press release | Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference |
| 2026-01-02 | Press release | Bristol Myers Squibb Announces Dividend Increase |
| 2025-11-07 | Presentation | Download business development brochure |
| 2025-02-06 | Press release | Press Release (PDF) |
| 2024-10-31 | Press release | Press Release (PDF) |
| 2024-07-26 | Press release | Press Release (PDF) |
| 2024-04-25 | Press release | Press Release (PDF) |
| 2024-02-02 | Press release | Press Release (PDF) |
| 2023-10-26 | Press release | Press Release (PDF) |
| 2023-07-27 | Press release | Press Release (PDF) |
| 2023-04-27 | Press release | Press Release (PDF) |
| 2023-02-02 | Press release | Press Release (PDF) |
| 2022-10-25 | Press release | Third Quarter 2022 Earnings Release |
| 2022-07-27 | Press release | Second Quarter 2022 Earnings Release |
| 2022-04-29 | Press release | First Quarter 2022 Earnings Release |